The United Laboratories International Holdings Limited (HKG:3933)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.54
+0.11 (1.05%)
Apr 2, 2026, 4:08 PM HKT
Market Cap20.79B -23.2%
Revenue (ttm)14.70B -4.0%
Net Income2.32B -21.6%
EPS1.23 -24.4%
Shares Out1.97B
PE Ratio8.56
Forward PE10.75
Dividend0.48 (4.53%)
Ex-Dividend DateJul 7, 2026
Volume15,238,000
Average Volume14,220,011
Open10.50
Previous Close10.43
Day's Range10.25 - 10.85
52-Week Range9.46 - 17.98
Beta0.39
RSI44.29
Earnings DateMar 24, 2026

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin... [Read more]

Sector Healthcare
Founded 1990
Employees 17,400
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3933
Full Company Profile

Financial Performance

In 2025, HKG:3933's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY Financial Statements